These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38215898)

  • 1. Application scenario-oriented molecule generation platform developed for drug discovery.
    Zheng L; Shi F; Peng C; Xu M; Fan F; Li Y; Zhang L; Du J; Wang Z; Lin Z; Sun Y; Deng C; Duan X; Wei L; Zhao C; Fang L; Zhang P; Ma S; Lai L; Yang M
    Methods; 2024 Feb; 222():112-121. PubMed ID: 38215898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning.
    Zhang H; Huang J; Xie J; Huang W; Yang Y; Xu M; Lei J; Chen H
    J Chem Inf Model; 2024 Feb; 64(3):666-676. PubMed ID: 38241022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Molecule Design by Translating from Reduced Graphs to SMILES.
    Pogány P; Arad N; Genway S; Pickett SD
    J Chem Inf Model; 2019 Mar; 59(3):1136-1146. PubMed ID: 30525594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinvent 4: Modern AI-driven generative molecule design.
    Loeffler HH; He J; Tibo A; Janet JP; Voronov A; Mervin LH; Engkvist O
    J Cheminform; 2024 Feb; 16(1):20. PubMed ID: 38383444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaffold-Constrained Molecular Generation.
    Langevin M; Minoux H; Levesque M; Bianciotto M
    J Chem Inf Model; 2020 Dec; 60(12):5637-5646. PubMed ID: 33301333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OptiMol: Optimization of Binding Affinities in Chemical Space for Drug Discovery.
    Boitreaud J; Mallet V; Oliver C; Waldispühl J
    J Chem Inf Model; 2020 Dec; 60(12):5658-5666. PubMed ID: 32986426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MERMAID: an open source automated hit-to-lead method based on deep reinforcement learning.
    Erikawa D; Yasuo N; Sekijima M
    J Cheminform; 2021 Nov; 13(1):94. PubMed ID: 34838134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magicmol: a light-weighted pipeline for drug-like molecule evolution and quick chemical space exploration.
    Chen L; Shen Q; Lou J
    BMC Bioinformatics; 2023 Apr; 24(1):173. PubMed ID: 37101113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
    Kang KM; Lee I; Nam H; Kim YC
    Eur J Med Chem; 2022 Oct; 240():114556. PubMed ID: 35849939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-principled deep generative models for designing drug combinations as graph sets.
    Karimi M; Hasanzadeh A; Shen Y
    Bioinformatics; 2020 Jul; 36(Suppl_1):i445-i454. PubMed ID: 32657357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for Design of Molecular Structures with a Desired Pharmacophore Using Deep Reinforcement Learning.
    Yoshimori A; Kawasaki E; Kanai C; Tasaka T
    Chem Pharm Bull (Tokyo); 2020; 68(3):227-233. PubMed ID: 32115529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLDM: hit molecule generation with constrained graph latent diffusion model.
    Wang C; Ong HH; Chiba S; Rajapakse JC
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38581415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.